Beatriz R. G.
- Country
- France
- Department
- Oncology
Research Overview
- Comparative Evaluation of Giredestrant and Triptorelin Versus Anastrozole and Triptorelin in Premenopausal ER-Positive/HER2-Negative Early Breast Cancer
- Evaluation of Metformin for Hyperglycemia Prevention in HR+/HER2- PIK3CA-Mutated Advanced Breast Cancer Patients on Alpelisib and Endocrine Therapy
- Phase 3 Randomized Open-Label Study of OP-1250 Versus Standard of Care in ER+, HER2- Advanced or Metastatic Breast Cancer Post-Endocrine and CDK4/6 Inhibitor Therapy
Data & Insights
Has run more than one trial at 14 of 120 partner sites.
Specializations
Breast Cancer Specialization
The investigator focuses on advanced therapeutic approaches for hormone receptor-positive breast cancer, with particular emphasis on ER-positive/HER2-negative breast cancer treatments.
- Early-stage breast cancer interventions
- Metastatic breast cancer management
- Hormone therapy optimization
Their research encompasses both early-stage and advanced disease states, exploring novel therapeutic combinations.
Endocrine Therapy Innovation
The investigator specializes in developing and evaluating novel endocrine therapy approaches, particularly in premenopausal patients with breast cancer.
- Hormone receptor targeting strategies
- Endocrine resistance management
- Treatment sequencing optimization
Their work includes investigation of innovative hormonal agents and combination approaches for enhanced therapeutic outcomes.
Advanced Treatment Modalities
The investigator explores targeted therapeutic strategies for breast cancer, including research into CDK 4/6 inhibitor therapy and subsequent treatment options.
- Novel therapeutic agent evaluation
- Treatment resistance solutions
- Comparative therapy assessment
Their research includes evaluation of new compounds against standard of care treatments in advanced breast cancer settings.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.